Literature DB >> 9562040

HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection.

M A Beilke1, S Japa, D G Vinson.   

Abstract

Coinfections with HIV-1 and HTLV-I or HTLV-II have been associated with unique immunophenotypes and an increased risk for development of neurodegenerative conditions. These findings may result from an increased HTLV-I or II viral burden in dually infected individuals. To investigate this possibility, HTLV-I/II tax/rex messenger RNA and viral antigen expression in peripheral blood mononuclear cells (PBMCs) were measured in 37 HTLV-I- or HTLV-II-infected subjects with or without HIV-1 coinfection. Tax/rex messenger RNA was detected in 14 of 24 PBMC samples from dually infected subjects, compared with only 1 of 13 PBMC samples from singly infected subjects (58% versus 7%; p < .003). The reverse transcription-polymerase chain reaction (RT-PCR) assay correlated with HTLV-I/II viral antigen detection in PBMC cultures but not with HIV-1 viral load levels in plasma. These findings may provide clues regarding the pathophysiologic consequences of HIV/HTLV-I and HIV/HTLV-II coinfections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562040     DOI: 10.1097/00042560-199804150-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  8 in total

1.  Human T cell leukaemia virus type 2 tax protein mediates CC-chemokine expression in peripheral blood mononuclear cells via the nuclear factor kappa B canonical pathway.

Authors:  C S Barrios; L Castillo; H Zhi; C-Z Giam; M A Beilke
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

2.  Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1.

Authors:  J Ongrádi; H M Laird; J F Szilágyi; A Horváth; M Bendinelli
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia.

Authors:  M C Levin; M K Rosenblum; C H Fox; S Jacobson
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

Review 4.  Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.

Authors:  Kenneth E Ugen; Susan B Nyland
Journal:  Springer Semin Immunopathol       Date:  2006-10-13

Review 5.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research.

Authors:  Mark A Beilke
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02       Impact factor: 2.205

6.  Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.

Authors:  Upal Roy; Scott A Simpson; Debasis Mondal; Sandra Eloby-Childress; Elsa L Winsor; Mark A Beilke
Journal:  J Med Virol       Date:  2008-03       Impact factor: 2.327

Review 7.  Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.

Authors:  Tania H Mulherkar; Daniel Joseph Gómez; Grace Sandel; Pooja Jain
Journal:  Viruses       Date:  2022-09-14       Impact factor: 5.818

Review 8.  Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection.

Authors:  Abelardo Q-C Araujo
Journal:  Pathogens       Date:  2020-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.